ENTONOX (50% NITROUS OXIDE AND 50% OXYGEN) PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
|
|
- Brett Sims
- 5 years ago
- Views:
Transcription
1 ENTONOX (50% NITROUS OXIDE AND 50% OXYGEN) PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its aim is to ensure appropriate supply of Entonox. 2. The Guidance 2.1. Clinical condition Indication of situation/condition Relevant National Guidance for inclusion for patient exclusion Action if patient excluded Action if patient declines Additional Action to be taken Procedural pain. BNF for Children The patient must be able to co operate by holding the demand valve and breathing the gas on their own. If the patient is unable to hold the demand valve by themselves. Gas trapped in a part of the body where its expansion may be dangerous, such as air logged in an artery or artificial traumatic or spontaneous pneumothorax (collapsed lung). Air encephalography Severe injuries to the face and jaw. Head injuries with impairment of consciousness. Severe bullous emphysema. Gross abdominal distension. Myringoplasty. If the patient has recently had any eye surgery where injections of gas have been used Document in patient medical records. Consider other forms of analgesia/antipyretic. Refer to medical staff for prompt assessment. Document in patient medical notes. Discuss with medical staff the need for treatment. ne 2.2. Characteristics of Health Care Professionals Class of Healthcare professional for whom PGD is applicable and qualifications Specialist competencies or Registered nurses (RN(Child) or RSCN) with 12 months post registration experience. Agency or Bank nurses are not eligible to administer drugs under Patient Group Directions. Comply with NMC s of Medicine Management. Page 1 of 11
2 qualifications considered relevant to the medicines used in the direction. Competencies required: Continuing training and Education PGD workbook and Child Health Drug Workbook must be completed. Practical assessment must be completed (see competency framework). The responsibility for continuing education lies with the individual practitioner. Yearly updates will be provided through the Paediatric Pain Study morning Description of treatment Name and Form of Medicine, 50% nitrous oxide and 50% oxygen (Entonox) e.g. tablets Legal status Prescription Only Medicine (POM) / Prescription only Medicine. General Sales List (GSL), Pharmacy Only (PO) Licensed / Unlicensed / Offlicensed Licensed Dose/s (where range is It must be self-administered to prevent over absorption. applicable include criteria for deciding on a dose) Route/Method of Inhalation Administration Frequency of Administration As required Total dose/number of times Once only treatment can be administered over what time Side Effects of drugs (to Drowsiness include potential adverse Dry mouth reactions) and any Nausea or vomiting monitoring required Procedure for reporting Adverse Drug Reactions (ADR) Special consideration for patients receiving concurrent medication lnformation on follow-up treatment if needed Written / verbal advice for patient / carer before / after treatment. Method of recording supply / administration, names of HGP, patient identifiers, sufficient to enable audit trail. Trust Procedure: The event is recorded on DATIX Yellow card completed before sending to pharmacy t applicable Dependant on clinical condition Entonox advice sheet, RCHT905. Following your child s general anaesthetic or sedation advice sheet, RCHT1085. The PGD should be recorded on EPMA. If not an inpatient then it should be recorded in the patient's notes. Page 2 of 11
3 3. Monitoring compliance and effectiveness Element to be Compliance of following the PGD process will be yearly monitored Monitoring of drug doses will be monitored monthly. Lead Sarah Fox and Kim Philp Tool Frequency Reporting arrangements Acting on recommendations and Lead(s) Change in practice and lessons to be shared Retrospective audit of patient notes for auditing the PGD process (see appendix 3) EPMA report will be used to monitor doses. A full audit using the attached tool will be completed yearly and a report will be written. EPMA reports are produced monthly The report will be shared at the Paediatric audit and guidelines meeting and the PGD working Group. Monthly monitoring of doses using the EPMA report will be shared with the Matron for Child Health. Paediatric audit and Guidelines PGD working group Required actions will be identified and completed in a specified timeframe Required changes to practice will be identified and actioned within 3-6 months. A lead member of the team will be identified to take each change forward where appropriate. Lessons will be shared with all the relevant stakeholders 4. Equality and Diversity 4.1. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement which can be found in the 'Equality, Diversity & Human Rights Policy' or the Equality and Diversity website Equality Impact Assessment The Initial Equality Impact Assessment Screening Form is at Appendix 2. Page 3 of 11
4 Appendix 1. Governance Information Document Title Date Issued/Approved: 11 Dec 15 Entonox (50% nitrous oxide and 50% oxygen) Patient Group Direction Child Health Date Valid From: 1 Jan 16 Date Valid To: 1 Jan 19 Directorate / Department responsible (author/owner): Sarah Fox Acute Paediatric Pain Service Contact details: Brief summary of contents Describes the process for supplying Entonox in the Child Health Department using a PGD Suggested Keywords: Target Audience Executive Director responsible for Policy: PGD, Entonox, Paediatric, Children RCHT PCH CFT KCCG Medical Director Date revised: 1 Jan 2016 This document replaces (exact title of previous version): Approval route (names of committees)/consultation: Divisional Manager confirming approval processes Name and Post Title of additional signatories Entonox (50% nitrous oxide and 50% oxygen) Patient Group Direction Child Health Medicines Practice Committee PGD working group (child health) Dr Julian Berry Dr Julian Berry, Paediatric Consultant Anaesthetist Mary Baulch/Mel Gilbert, Matron for Child Health Phil Dale, Paediatric Pharmacist Name and Signature of Divisional/Directorate Governance Lead confirming approval by specialty and divisional management meetings {Original Copy Signed} Name: Helen Ross-McGill Page 4 of 11
5 Signature of Executive Director giving approval Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Links to key external standards Related Documents: Training Need Identified? {Original Copy Signed} Internet & Intranet Clinical / Paediatric Intranet Only NICE(2013) Good practice guidelines- Patient Group Directions BNF for Children Comply with NMC s of Medicine Management. PGD workbook and Child Health Drug Workbook must be completed. (See competency framework- Procedural Guidelines for Developing, Implementing and Reviewing the Supply or Administration of Medicines under a Patient Group Direction (PGD)). Version Control Table Date Version 10 Jan 12 V1.0 Initial Issue 1 Jan 14 V2.0 Full review, reformat. 1 Jan 16 V3.0 Summary of Changes PGD reapproved by MPC Changes Made by (Name and Job Title) Sarah Fox Acute Paediatric Pain Service Sarah Fox Acute Paediatric Pain Service Sarah Fox Acute Paediatric Pain Service All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of expiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager. Page 5 of 11
6 Page 6 of 11
7 Appendix 2. Initial Equality Impact Assessment Form Name of Name of the strategy / policy /proposal / service function to be assessed (hereafter referred to as policy) (Provide brief description): Entonox (50% nitrous oxide and 50% oxygen) Patient Group Direction Child Health Directorate and service area: Is this a new or existing Policy? Existing Clinical / Paediatric Name of individual completing Telephone: assessment: Sarah Fox, Paediatric Pain Team 1. Policy Aim* As per paragraph 1 of this document. Who is the strategy / policy / proposal / service function aimed at? 2. Policy Objectives* As per paragraph 1 of this document. 3. Policy intended Outcomes* 4. *How will you measure the outcome? 5. Who is intended to benefit from the policy? 6a) Is consultation required with the workforce, equality groups, local interest groups etc. around this policy? b) If yes, have these *groups been consulted? C). Please list any groups who have been consulted about this procedure. 7. The Impact Please complete the following table. Are there concerns that the policy could have differential impact on: Equality Strands: Rationale for Assessment / Existing Evidence Age Sex (male, female, transgender / gender reassignment) As per paragraph 1 of this document. As per paragraph 3 of this document. All paediatric patients. Page 7 of 11
8 Race / Ethnic communities /groups Disability - Learning disability, physical disability, sensory impairment and mental health problems Religion / other beliefs Marriage and civil partnership Pregnancy and maternity Sexual Orientation, Bisexual, Gay, heterosexual, Lesbian You will need to continue to a full Equality Impact Assessment if the following have been highlighted: You have ticked in any column above and consultation or evidence of there being consultation- this excludes any policies which have been identified as not requiring consultation. or Major service redesign or development 8. Please indicate if a full equality analysis is recommended. 9. If you are not recommending a Full Impact assessment please explain why. Signature of policy developer / lead manager / director Date of completion and submission Names and signatures of members carrying out the Screening Assessment 1. Sarah Fox 2. Keep one copy and send a copy to the Human Rights, Equality and Inclusion Lead, c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Knowledge Spa, Truro, Cornwall, TR1 3HD A summary of the results will be published on the Trust s web site. Signed Sarah Fox Date 4 Jan 16 Page 8 of 11
9 Appendix 3- Audit tool PATIENT GROUP DIRECTIONS (PGD) AUDIT- 411 AREA OF AUDIT... NAME OF AUDITOR... DATE OF AUDIT.. 1. : The PGD documentation is accessible and up to date Practitioners surveyed confirmed that the PGD is accessible for reference at consultations (min number surveyed 10% of signatories) 100% 10 staff Copies of the PGD are located in the areas stated within the PGD 100% 1 area 2. : Local practice meets the standards detailed within the PGD Patients treated under the PGD for stated clinical indication only. (Min number of patient records surveyed should be at least 20 records or 50% (whichever is smaller)). Patients included for treatment under the PGD fit the inclusion criteria. The practitioners operating under the PGD are confirmed as competent to use PGDs (surveyed 10% of signatories) Page 9 of 11
10 3. : The following information is recorded in the patient record by the practitioners using the PGD (min number of patient records surveyed should be at least 20 records or 50% (whichever is smaller)). The name of the medicine The dose of the medicine The practitioners name The date when the patient received treatment under the PGD The practitioners signature Page 10 of 11
11 : The minimum records kept for audit purposes: (Gwithian and PAC only) The date of supply (record sheets) 100% 5 The patients name (record sheets) 100% 5 A unique identifier for the patient (NHS no) (record sheets) The practitioners name (record sheets) 100% 5 100% 5 4. : The reporting of adverse of clinical incidents (min number of patient records surveyed at least 20 records, or 50% (whichever is smaller)) Any adverse clinical incidents involving the medicine have been recorded via the local clinical incident reporting policy 0% N/A of incidents identified 5. : Education and training for using a PGD There is an individual identified who is responsible for ensuring the practitioners are trained and competent. (NB: training records should be available) Individual training records indicate that practitioners are ensuring they are updated. (min sample 10% of signatories) PGD update is included within paediatric pain study morning. 100% 100% N/A Page 11 of 11
PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationIBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationCLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical
More informationClinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline
Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide anaesthetists with an algorithm to work with when dealing with
More informationLoading Dose Worksheet for Oral Amiodarone
This applies to adult patients only Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Prescribe as per loading dose worksheet below End 1. Aim/Purpose of this Guideline 1.1.
More informationCLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline To provide guidance for appropriate referral to the acute pain service for in-patient review. 2. The Guidance PAIN SERVICES
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline aims to improve outcomes for patients presenting with sepsis or developing sepsis
More informationCLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS)
CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS) 1. Aim/Purpose of this Guideline 1.1. Pain is whatever the experiencing person says it is, existing whenever the experiencing person
More informationPolicy on Governance Arrangements Relating to Medicines V2.0
V2.0 August 2015 Summary. The policy outlines the governance arrangements for medicines within the Trust, specifically; 1. The committee structure in the Trust and the county for medicine related matters
More informationPolicy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0
Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0 January 2016 Summary. This policy applies only to selected staff within the Haematology Department at the
More informationCLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline 1.1. Guidelines for the use of rectus sheath catheters for the management of pain following laparotomy
More informationCLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of for the management of Adult patients with Mellitus
More informationA list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Colposcopist within Colposcopy Dept. Royal Cornwall Hospital 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse Colposcopist
More informationClinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.
Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Obtain brief medical history including allergies & renal function. Informed verbal consent gained and documented and procedure and
More informationCLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS
CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline This guideline is to support the use of bed and chair sensor alarm
More information1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Endoscopist (Lower GI) within the Royal Cornwall Hospitals Trust 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse
More informationCLINICAL GUIDELINE FOR: Management of low-risk upper GI haemorrhage. Page 1 of 10. Management of low-risk upper GI haemorrhage
CLINICAL GUIDELINE FOR: Page 1 of 10 Summary AGE
More informationClinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline
Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist. 1. Aim/Purpose of this Guideline 1.1 This protocol applies to upper & lower GI Non medical Endoscopist
More informationDiagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging
Diagnostic Test Reporting & Acknowledgement Procedures V2.0 November 2014 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5.
More informationCLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE
CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE CLINICAL GUIDELINE V4. Summary. Start The non-medical practitioner
More informationThis guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.
CLINICAL GUIDELINE FOR THE SAFE ADMINISTRATION OF BOTULINUM NEURO TOIN FOR INJECTION within the PAIN SERVICE. Botox and eomin (trade names) 1. Aim/Purpose of this Guideline This guideline is for nursing
More informationCLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start
CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start The non-medical practitioner has received sufficient training to make clinical
More informationDiagnostic Testing Procedures in Urodynamics V3.0
V3.0 09 01 18 Table of Contents Summary.... 1. Introduction... 3 1.1. Diagnostic testing information... 3 2. Purpose of this Policy/Procedure... 3 2.1. Approved Document Process... 3 3. Scope... 3 3.1.
More information2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite
ADVANCED NEONATAL NURSE PRACTITIONERS (ANNPs) BLOOD COMPONENT AND BLOOD PRODUCT REQUESTING PROTOCOL NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 The purpose of this protocol is to guide
More informationCLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0
CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0 Page 1 of 13 Abbreviation (P/A)HDU (P/A)ICU GCS IPPV CPAP BiPAP DKA Reg Meaning (Paediatric/Adult) High Dependency
More informationOXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0
OYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline 1.1 To provide guidance on the assessment and management of infants requiring oxygen therapy
More informationSchool Vision Screening Policy V2.0
School Vision Screening Policy V2.0 05 April 2016 Summary. Vision screening test in school PASS Visual acuity LogMAR 0.2 both eyes Kays 0.1 both eyes Outcome letter sent home Test result information put
More informationESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline
ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline 1.1. This guidance is designed to aid staff to monitor capacity and staffing in Child Health. 2. The Guidance 2.1. The majority
More informationThe initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0
The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0 October 2016 Summary. Start See section 6.2 of this document for important information regarding
More informationSafe Bathing Policy V1.3
V1.3 April 2018 Summary Safe hot water temperatures The hot water distribution temperatures, which are required for the control and prevention of Legionella, can lead to discharge temperatures in excess
More information2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures.
Was Not Brought, Cancellation and Refusal of Appointments Policy for Children and Young People up to the Age of 18 Years (up to the age of 25 years for people with a Learning Disability) 1. Aim/Purpose
More informationWARD CLOSURE POLICY V
WARD CLOSURE POLICY V3.0 29.07.15 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 4 5.1.
More informationNewborn Hearing Screening Programme Policy
Newborn Hearing Screening Programme Policy V3.0 December 2015 Page 1 of 16 Summary - Screening Pathway for Newborn Hearing Screening Newborn hearing screening Check eligibility Eligible for screening Not
More informationSafeguarding Children Supervision Policy V4.0. November 2016
Safeguarding Children Supervision Policy V4.0 November 2016 Page 1 of 20 Summary Part 1 Part 2 Safeguarding supervision for Nursing and Midwifery staff, Paediatricians, Medical Staff and other Allied Health
More informationCLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND
CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND 1. Aim/Purpose of this Guideline The aim of this guideline to enable the effective care of patients needing emergency defill of
More informationPRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0
PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline
More informationMANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline
MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 This guideline aimed at all clinical staff responsible for the management of infants
More informationDiagnostic Testing Procedures in Neurophysiology V1.0
V1.0 10 September 2012 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the
More informationProcedure for the Application of a Cast and its subsequent care V1.3
Procedure for the Application of a Cast and its subsequent care V1.3 May 2015 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary...
More informationTissue Viability Referral Pathway. April 2017
Tissue Viability Referral Pathway V4 April 2017 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...
More informationCEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline
CEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. To provide guidance on the operation and interpretation of Cerebral Function Monitoring (CFM) in neonates.
More informationDiagnostic Testing Procedures for Ophthalmic Science
V4.0 01/08/17 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the Managers... 3 5.3.
More informationPatient Experience Strategy
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationHealth and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0
Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0 January 2016 Summary Purpose of the document: The purpose of this policy is to provide an outline of the requirements
More informationOccupational Health Surveillance Policy V2.1
Occupational Health Surveillance Policy V2.1 May 2016 Table of Contents 1. Introduction... 2 2. Purpose of this Policy... 2 3. Scope... 2 4. Definitions/Glossary... 3 5. Ownership and Responsibilities...
More informationSafe Staffing Levels for. Midwifery, Nursing and Support Staff. For Maternity Service - Approved. Document V1.5. June 2017
Safe Staffing Levels for Midwifery, Nursing and Support Staff For Maternity Service - Approved V1.5 June 2017 Jan Walters Head of Midwifery Women, Children and Sexual Health Division CONTENTS Section Page
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients
The Newcastle upon Tyne Hospitals NHS Foundation Trust Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients Version.: 2.0 Effective From: 15 March 2018 Expiry Date: 15 March
More informationCLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary.
CLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary. Start Elective procedure identified, blood requirement listed in guideline Patient attends PAC and has a group and screen (G&S)
More informationCLINICAL GUIDELINE FOR TRANSFERS AND DISCHARGES IN THE LAST FEW WEEKS OF LIFE 1. Aim/Purpose of this Guideline
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Use of Patients Own Drugs (PODs)
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Use of Patients Own Drugs (PODs) Version.: 2.2 Effective From: 20 January 2016 Expiry Date: 20 January 2019 Date Ratified: 13 January 2016 Ratified
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage
The Newcastle upon Tyne Hospitals NHS Foundation Trust Strong Potassium Solutions Safe Handling and Storage Version : 5.3 Effective From: 19 January 2016 Expiry Date: 19 January 2019 Date Ratified: 14
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Version No: 5.0 Effective From: 7 September 2017 Expiry Date: 31 August 2018 Date Ratified: 30 August 2017 Ratified By: Executive Team 1 Introduction
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Access to Drugs Policy Version No.: 3.0 Effective From: 25 January 2016 Expiry Date: 25 January 2019 Date Ratified: 4 November 2015 Ratified By: Medicines
More informationNHS Fife. Patient Group Direction for Named Community Pharmacists to Supply
Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Strategy for Non-Medical Prescribing Version No: 2.2 Effective From: 19 October 2016 Expiry Date: 19 October 2019 Date Ratified: 12 October 2016 Ratified
More informationSevere Weather Plan V5.5 March 2018
V5.5 March 2018 Table of Contents 1. Introduction 3 2. Purpose of this Plan. 3 3. Scope. 3 4. Ownership and Responsibilities. 3 5. Escalation Levels and Actions 5 6. Staffing Contingency and Guidance.
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust
The Newcastle upon Tyne Hospitals NHS Foundation Trust Procedure for registration and supply of prophylaxis to the immediate household contacts of patients admitted with meningococcal disease Version.:
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact
The Newcastle upon Tyne Hospitals NHS Foundation Trust Code of Practice for Wound Care Company Representatives and Staff with whom they interact Version No.: 1.1 Effective From: 8 th January 2015 Expiry
More informationCLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)
CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration
More informationRCHT Non-Ionising Radiation Safety Policy
V3.0 June 2015 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 4 4. Definitions / Glossary... 5 5. Ownership and Responsibilities... 5 6. Standards and Practice...
More informationHand Hygiene Policy V2.1
V2.1 October 2017 Summary. Effective hand hygiene is shown to significantly reduce the carriage of potential pathogens and decrease the risk and occurrence of healthcare associated infections. Each individual
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Injectable Medicines Policy Version No.: 4.3 Effective From: 24 March 2017 Expiry Date: 21 January 2019 Date Ratified: 11 January 2017 Ratified By:
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Key Control Operational Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Key Control Operational Policy Version.: 1.0 Effective From: 18 January 2016 Expiry Date: 18 January 2019 Date Ratified: 22 December 2015 Ratified
More informationCLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage
CLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage Suspected Non Variceal upper GI haemorrhage If any features suggest liver disease consult the variceal haemorrhage guideline http://www.rcht.nhs.uk/documentslibrary/royalcornw
More informationNHS Lothian Patient Group Direction Version: 001
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% TO TREAT MINOR STAPHYLOCOCCAL SKIN INFECTIONS (IMPETIGO) IN PATIENTS AGED OVER 2 YEARS BY PHARMACISTS WORKING WITHIN NHS LOTHIAN COMMUNITY
More informationAppendix 3 Cardiac Catheter Lab at Musgrove Park Hospital PATIENT GROUP DIRECTION (PGD)
Appendix 3 Cardiac Catheter Lab at Musgrove Park Hospital PATIENT GROUP DIRECTION (PGD) PGD for the supply/administration of: Lidocaine 1% and Adrenaline 1:200,000 Master document reference number: This
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Water Safety Policy Version No.: 2.0 Effective From: 09 February 2018 Expiry Date: 09 February 2021 Date Ratified: 09 November 2017 Ratified By: Infection
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines
The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain
More informationEarly detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0
Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0 01.05.2018 Summary - Patient admission flow chart for the infection prevention and control of carbapenemase-producing
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Procedure for Monitoring of Delayed Transfers of Care
The Newcastle upon Tyne Hospitals NHS Foundation Trust Procedure for Monitoring of Delayed Transfers of Care Version No.: 2.2 Effective From: 17 March 2015 Expiry Date: 17 March 2018 Date Ratified: 25
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationPHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives
PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy
More informationGG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria:
More informationPerson/persons conducting this assessment with Contact Details Marilyn Rees Lead VTE Nurse ext 48729
Appendix 2 - Equality Impact Assessment - Thromboprophylaxis Policy for Adult In-Patients Section A: Assessment Name of Policy Thromboprophylaxis Policy for Adult In-Patients Person/persons conducting
More informationPatient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.
Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for
More informationVersion: Date Adopted: 20 October Name of responsible Committee: Date issue for publication: Review Date: March 2018
Medical Gases Policy This policy sets out LPT s arrangements for the provision and management of Medical Gases used within the Trust. Key Words: Version: Adopted by: Medical, Gases V3 Quality Assurance
More informationMedicines Reconciliation Policy
Medicines Reconciliation Policy Lead executive Medical Director Authors details Senior Clinical Pharmacy Technician - 01244 39 7494 Document level: Trustwide (TW) Code: MP19 Issue number: 3 Type of document
More informationSTANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.
STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION. Issue History Oct 12 Issue Version Two Purpose of Issue/Description of Change To ensure implementation
More informationMedical Needs Policy. Policy Date: March 2017
Medical Needs Policy Policy Date: March 2017 Renewal Date: March 2017 Equality Statement This policy takes into account the provisions of the Equality Act 2010 and advances equal opportunities for all.
More informationDocument Title: Training Records. Document Number: SOP 004
Document Title: Training Records Document Number: SOP 004 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationSTANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES
STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES First Issued Issue Version One Purpose of Issue/ Description of Change To promote the safe administration
More informationyour hospitals, your health, our priority CATHETERISATION Urethral/ supra-pubic POLICY NAME: VERSION NUMBER : 1 PROFESSIONAL ADVISORY BOARD (PAB)
POLICY NAME: POLICY REFERENCE: CATHETERISATION Urethral/ supra-pubic TW12/016 VERSION NUMBER : 1 APPROVING COMMITTEE: PROFESSIONAL ADVISORY BOARD (PAB) DATE THIS VERSION APPROVED: RATIFYING COMMITTEE:
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Ventilation Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Ventilation Policy Version.: 1.0 Effective From: 15 January 2016 Expiry Date: 15 January 2019 Date Ratified: 22 December 2015 Ratified By: Estates
More informationThe Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy
The Newcastle upon Tyne NHS Hospitals Foundation Trust Version No.: 4.2 Effective From: 27 October 2015 Expiry Date: 27 October 2018 Date Ratified: 1 July 2015 Ratified By: Clinical Risk Group 1 Introduction
More informationThe Use of Non-Invasive Ventilation in Patients with Acute Type 2 Respiratory Failure
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationORAL ANTI-CANCER THERAPY POLICY
ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive
More informationPOLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case
POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk
More informationPatient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian
NHS Grampian Patient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian Lead Author: Consultation Group: Approver: Highly
More informationNMC programme of change for education Prescribing and standards for medicines management
NMC programme of change for education Prescribing and standards for medicines management This response form relates to our consultation on nurse and midwifery prescribing competency proposals, programme
More informationName Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019
PGD4017 PATIENT GROUP DIRECTION FOR THE SUPPLY OF ACICLOVIR TABLETS FOR THE TREATMENT OF GENITAL HERPES SIMPLEX INFECTIONS by registered nurses and midwives in Integrated Sexual Health services employed
More informationNOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST MEDICINES CODE OF PRACTICE MEDICINES MANAGEMENT WHEN PATIENTS ARE DISCHARGED FROM HOSPITAL
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST MEDICINES CODE OF PRACTICE MEDICINES MANAGEMENT WHEN PATIENTS ARE DISCHARGED FROM HOSPITAL Reference CL/MM/024 Date approved 13 Approving Body Directors Group
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-Operative Marking
The Newcastle upon Tyne Hospitals NHS Foundation Trust Pre-Operative Marking Version.: 6.1 Effective From: 01 April 2015 Expiry Date: 01 April 2018 Date Ratified: 17 December 2014 Ratified By: Theatre
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Employment Policies and Procedures. Breastfeeding Supporting Staff Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Employment Policies and Procedures Breastfeeding Supporting Staff Policy Version No.: 2.1 Effective From: 20 June 2018 Expiry Date: 30 June 2020 Date
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Protected Mealtime Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Protected Mealtime Policy Version No 3 Effective From 12 February 2018 Expiry date 12 February 2021 Date Ratified 01 November 2017 Ratified By Nutritional
More informationAnimals and Pets in Healthcare Facilities Policy
Animals and Pets in Healthcare Facilities Policy Post holder responsible for Procedural Document Author of Guideline Division/ Department responsible for Procedural Document Contact details Judy Potter,
More informationExchange Transfusion Neonatal Clinical Guideline V1.0 February 2018
Exchange Transfusion Neonatal Clinical Guideline V1.0 February 2018 1. Aim/Purpose of Guideline To help staff manage significant jaundice safely and prevent complications of brain damage and kernicterus.
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Named Key Worker for Cancer Patients Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Named Key Worker for Cancer Patients Policy Version No.: 4 Effective 07 December 2017 From: Expiry Date: 07 December 2020 Date Ratified: 17 October
More information